Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement (Q35553375)
Jump to navigation
Jump to search
scientific article published on October 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement |
scientific article published on October 2004 |
Statements
1 reference
Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement (English)
1 reference
Valesini G
1 reference
Tincani A
1 reference
Alessandri C
1 reference
Bombardieri M
1 reference
Papa N
1 reference
Cinquini M
1 reference
Magrini L
1 reference
1 October 2004
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference